Similar articles

• Functional recovery from acute rejection as a guide to ultimate renal graft survival.

  Silcott GR, Barbour BH, Mendez R, Bischel MD, Berne TV. Silcott GR, et al. Arch Surg. 1972 Jun;104(6):791-3. doi: 10.1001/archsurg.1972.04180060041010. Arch Surg. 1972. PMID: 4555178 No abstract available.
• Prednisone used as treatment for rejection correlates with poor outcome.

  Toussaint RM, Callender CO, Dunston GM, Flores J, Walters CS, John D, Yeager C, Bond O, Thompson C, Gear JC. Toussaint RM, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):1712-5. Transplant Proc. 1989. PMID: 2652561 No abstract available.
• Improvement in cadaveric renal transplant survival.

  Beaudoin JG, Guttmann RD, Morehouse DD, Knaack J, Chassot PG. Beaudoin JG, et al. Arch Surg. 1973 Aug;107(2):245-9. doi: 10.1001/archsurg.1973.01350200107023. Arch Surg. 1973. PMID: 4578273 No abstract available.
• Antirejection drugs and procedures.

  Chatterjee SN. Chatterjee SN. Am J Surg. 1973 Nov;126(5):678-82. doi: 10.1016/s0002-9610(73)80021-2. Am J Surg. 1973. PMID: 4129988 Review. No abstract available.
• The utility of cyclosporine weaning in renal transplantation.

  Loertscher R, Blier L, Steinmetz O, Nohr C. Loertscher R, et al. Ann Surg. 1992 Apr;215(4):368-76. doi: 10.1097/00000658-199204000-00011. Ann Surg. 1992. PMID: 1558418 Free PMC article. Review.